Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related to Alzheimer's disease in individuals with mild cognitive impairment ...

James Davis; Executive Chairman of the Board, President, Chief Executive Officer; Quest Diagnostics Inc Sam Samad ... of our novel PFAS forever chemicals test, which we launched a little over ...

Quest Diagnostics posted first-quarter revenue growth ... Further, the additional test volume from the following collaborations reinforces Quest's cost advantage. Optum Health, the largest US ...